Sunflower Protein May Help Block Tumor Spread in Prostate Cancer

By Biotechdaily staff writers
Posted on 27 May 2008
A mini-protein found in sunflower seeds could be the key to stopping tumors spreading in prostate cancer patients, according to Australian researchers.

Dr. Jonathan Harris, a senior lecturer in Queensland University of Technology's (QUIT; Brisbane, Australia) Faculty of Science, and Ph.D. student Joakim Swedberg, from both the University's Institute of Health and from Biomedical Innovation, are working on the naturally occurring molecule.

"We are interested in this miniprotein as a potential treatment of prostate cancer, in particular for those patients who relapse,” said Dr Harris. "We are interested in this miniprotein as a potential treatment of prostate cancer, in particular for those patients who relapse. The best thing to do in those cases is block the disease spreading to other organs, particularly the spine, which is very debilitating; it is not the prostate tumor that kills you, it is when the cancer cells escape from the prostate so we want to prevent that.”

Another QUT researcher, Prof. Judith Clements, had previously demonstrated that the action of enzymes called proteases was a critical process in metastasis, and Dr. Harris reported that the sunflower mini-protein, known as the protease inhibitor, was able to block these enzymes in test tube-based assays.

"However, it also inhibits a whole range of proteases, some of which control important processes in the body, so we have re-engineered the molecule so it should just block the proteases produced in prostate cancer and hence stop tumor spreading, whilst leaving other processes intact,” Dr. Harris remarked.

Dr. Harris and his team will perform tests on the re-engineered inhibitor in animals over the next months. "It feels like we have been covered in a shower of gold at the moment, it is very exciting for us because we are a small team but we have been working very hard on this for a long time,” he said. "We are extremely happy because now we can carry out trials in mouse-models of prostate cancer and if we have positive results, we could get a pharmaceutical industry partner interested in the work. "Currently bluebox, QUT's commercialization company, is helping us towards that goal. The dream end-product is having a drug which could be produced in sunflower seeds and given as a simple dietary supplement for people with prostate cancer.”


Related Links:
Queensland University of Technology

Latest BioResearch News